Liza Squires
Technik-/Wissenschafts-/F&E-Leiter bei NEUREN PHARMACEUTICALS LIMITED
Profil
Liza Squires is currently the Chief Medical Officer at Neuren Pharmaceuticals Ltd.
She previously worked as the Director of Paediatric Neurology at Helen DeVos Children's Hospital, and as the Chief Medical Officer at Zynerba Pharmaceuticals, Inc. and Lumos Pharma Sub, Inc. She holds a doctorate degree from Michigan State University and an undergraduate degree from the University of Michigan.
Aktive Positionen von Liza Squires
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 08.07.2022 |
Ehemalige bekannte Positionen von Liza Squires
| Unternehmen | Position | Ende |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2018 |
Helen DeVos Children's Hospital
 Helen DeVos Children's Hospital Hospital/Nursing ManagementHealth Services Helen DeVos Children's Hospital operates as a children's hospital. The private company is based in Grand Rapids, MI. | Corporate Officer/Principal | - |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Liza Squires
| Michigan State University | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Health Technology |
| ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Health Services |
Helen DeVos Children's Hospital
Helen DeVos Children's Hospital Hospital/Nursing ManagementHealth Services Helen DeVos Children's Hospital operates as a children's hospital. The private company is based in Grand Rapids, MI. | Health Services |
